| GTO ID | GTC0811 |
| Trial ID | ChiCTR1900024632 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Chimeric Antigen Receptor-transduced T cell (CAR-T) therapy for Relapsed or Refractory B-cell Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | Beijing Shijitan Hospital, Capital Medical University |
| Cohort 1 | |||||||
|
|||||||